- Home
- ARCT vs PIM Comparison
ARCT vs PIM Comparison
Compare ARCT & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARCT | PIM |
|---|---|---|
| Founded | 2013 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.4M | 153.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARCT | PIM |
|---|---|---|
| Price | $15.63 | $3.18 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $24.11 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 40.8K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.28% |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $82,031,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.77 | N/A |
| P/E Ratio | ★ N/A | $63.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.50 | $3.07 |
| 52 Week High | $24.14 | $3.50 |
Technical Indicators
Market Signals| Indicator | ARCT | PIM |
|---|---|---|
| Relative Strength Index (RSI) | 70.24 | 51.86 |
| Support Level | $6.47 | $3.14 |
| Resistance Level | N/A | $3.21 |
| Average True Range (ATR) | 1.67 | 0.03 |
| MACD | 0.13 | -0.00 |
| Stochastic Oscillator | 75.53 | 50.00 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About PIM Putnam Master Intermediate Income Trust
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.